Monica E. Kleinman
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Phase II Trial of Lonafarnib (a Farnesyltransferase Inhibitor) for Progeria (NCT00425607) | Monica E. Kleinman | 2007-05-01 |
Track Monica E. Kleinman automatically
Every clearance here is in the API, with alerts when new ones post.